Please Wait
Applying Filters...
menu
    • menu
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Voruciclib

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    MEI Pharma Reports Fiscal Year End 2024 Cash Position
    MEI Pharma Reports Fiscal Year End 2024 Cash Position

    19 Sep 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240919436864/en

    BUSINESSWIRE
    19 Sep 2024
    Share Share
    MEI Pharma Aligned On Voruciclib, ME-344 Strategy
    MEI Pharma Aligned On Voruciclib, ME-344 Strategy

    11 Apr 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240411560218/en

    BUSINESSWIRE
    11 Apr 2024
    Share Share
    MEI Update from Study Evaluating Voruciclib with Venetoclax in Patients with AML
    MEI Update from Study Evaluating Voruciclib with Venetoclax in Patients with AML

    26 Mar 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240326048347/en

    BUSINESSWIRE
    26 Mar 2024
    Share Share
    MEI Pharma Announces Update of PI Study Evaluating CDK9 Inhibitor Voruciclib
    MEI Pharma Announces Update of PI Study Evaluating CDK9 Inhibitor Voruciclib

    23 May 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230523005347/en

    BUSINESSWIRE
    23 May 2023
    Share Share